A partial agonist selective for α_4β_2 nicotinic acetylcholine receptor subtypes,varenicline
Bai Qiu-jiang
Abstract
Bai Qiu-jiang
Abstract
Varenicline is a partial agonist selective forα_4β_2 nicotinic aeetylcholine receptor subtypes. Varenicline binds with high affinity and selectivity atα_4β_2 nicotinic acetylcholine receptors.Varenieline blocks the ability of nicotine to activateα_4β_2 receptors and thus blocks the nervous transmission underlying reinforcement and reward experienced upon smoking.Varenicline is used for smoking cessation.This paper introduces mechanism of action,pharmacokinetics,clinical study,drug-drug interactions and adverse effects of varenicline.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Varenicline is a partial agonist selective forα_4β_2 nicotinic aeetylcholine receptor subtypes. Varenicline binds with high affinity and selectivity atα_4β_2 nicotinic acetylcholine receptors.Varenieline blocks the ability of nicotine to activateα_4β_2 receptors and thus blocks the nervous transmission underlying reinforcement and reward experienced upon smoking.Varenicline is used for smoking cessation.This paper introduces mechanism of action,pharmacokinetics,clinical study,drug-drug interactions and adverse effects of varenicline.
Key concepts: Varenicline, Partial agonist, Nicotinic agonist, Pharmacology, Nicotine, Agonist, Nicotinic acetylcholine receptor, Acetylcholine receptor